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Abstract
BACKGROUND: Cellulitis is a common infectious disease with typical feature – the tendency for recurrence.
AIM: The aim of the study was to define comorbidities, clinical, and laboratory – biochemical factors associated with 
longer length of stay (LOS) in patients with recurrent cellulitis in the lower legs.
MATERIALS AND METHODS: The study is a retrospective-cohort study conducted at the Department of 
Dermatovenerology at General Hospital in Skopje, from January 2016 to August 2019. In the study, we included and 
analyzed only hospitalized patients admitted for recurrent cellulitis on the lower legs. Inclusion in the study recorded 
the following variables – comorbid conditions in the patients – present in the medical records or obtained from the 
interview of the patient and initial values of laboratory assays on admission.
RESULTS: The study included hospitalized 205 patients, admitted for recurrent cellulitis. The most significant 
comorbid conditions and laboratory parameters which correlate with increased LOS are as follows: Type 2 diabetes 
mellitus – insulin dependent (p < 0.001), chronic renal failure (p = 0.003), ischemic heart disease (p = 0.006), 
peripheral arterial disease (p = 0.007), fever ≥38.0°C (p < 0.001), hypoalbuminemia <34 g/L (p < 0.001), elevated 
value of C-reactive protein >10 mg/L (p < 0.001), and leukocytosis >109 L (p = 0.009).
CONCLUSION: Cellulitis is potential medical emergency event. Recurrence is the most significant complication of 
cellulitis and lower legs cellulitis is associated with a risk for long-term morbidity. The study has identified several 
independent factors that are significantly associated with an increased LOS. This independent factors present on 
admission can stratify the patient with the highest risk of mortality, can improve patient care for better outcomes, and 
decrease the number of relapses and hospital readmissions.
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Introduction
Cellulitis is a soft-tissue infection that affects the 
deep dermis and subcutaneous tissue and erysipelas 
is a common bacterial infection that affects the more 
superficial layers [1], [2]. Still, cellulitis can extend to the 
superficial and erysipelas to the deeper layers of the 
skin, and in many cases, both conditions accompany 
each other and it is impossible to make a significant 
distinction [3]. Nowadays, the erysipelas considers 
itself a form of cellulitis and not a separate entity [3].
The traditional teaching is that most commonly, 
cellulitis is caused by beta-hemolytic streptococcus 
(BHS) [4]. In its classical form is considered to be 
exclusively caused by Beta hemolytic Streptococcus 
(BHS) and most commonly Group A streptococcus 
(GAS) [1], [4]. BHS other than GAS may be associated 
with cellulitis – most commonly the G group [4]. Less 
frequently Group B is isolated from cases of acute 
and recurrent cellulitis [4]. Other than BHS, cellulitis 
somewhat is less frequently caused by Staphylococcus 
aureus [4].
Cellulitis most commonly is located on the lower 
legs [1], [2], [4]. The diagnosis is primary clinical and is 
based empirically on the cutaneous manifestations and 
systemic signs of infection [4]. The lower leg cellulitis has 
a distinct feature, that is, the tendency to reoccur. The 
incidence of recurrent cellulitis varies from study to study. 
The relapse rate is 8–20% per year [5]. In the study of 
Pavlotsky et al., a retrospective 3-year study there is a 
significantly higher relapse rate (higher than 45%) [6].
Several major retrospective studies have 
analyzed the epidemiology of cellulitis in the antibiotic 
era. In all of them, the incidence is markedly 
increased [5], [6], [7]. In the Dutch study of Goettsch 
et al., there was an overall increase in the number of 
hospitalizations per year [7]. The incidence increased 
from 1.7 to 22/1000 population between 2001 and 
2006 years, and an average of 7% of all patients with 
cellulitis being hospitalized [7]. This study analyzed 
the increased incidence, which correlated primarily 
with age, namely, it was 5 times higher in older patient 
group, 54–85 years [7]. The analysis has shown that 
an additional reason for the increase in the incidence 
is the increase of the population with various causes 
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of immunosuppression [7]. In the present time, the 
incidence of cellulitis is thought to be 200/100,000 
people per year, and it was observed most commonly 
in the oldest age groups [5].
The trend of increasing incidence is also 
seen in the increased number of hospitalizations for 
this disease in several global studies. A 2012 study of 
Phoenix et al. in the United States showed an increase 
rate in hospitalizations from 17.3 to 32.5/1000 residents 
a year, resulting in as many as 600,000 hospitalizations 
in 2010 or 3.7% of all hospitalizations in the emergency 
departments [8]. Cellulitis is a common disease whose 
incidence is increasing and is thought to be 10% of all 
infectious diseases associated with hospitalization in 
the United States [9]. In the UK, cellulitis is the primary 
diagnosis in 114,190 consultations in secondary health 
care and 75,838 hospitalizations with an average length of 
hospital stay of 3 days, and average age of the patients is 
63 years [10]. In Australia, the number of hospitalizations 
has grown to 11.5/10,000 population (2001–2002) with 
an average hospital stay of 5.9 days [11].
In this study, we analyzed risk factors associated 
with prolonged hospital stay in recurrent cellulitis. 
Accurate and precise identification of the risk factors 
will have significant implications for reducing morbidity 
of this disease, better therapeutic management, 
and stimulate the creation of appropriate preventive 
measures, especially in the patients with highest risk.
Methods
This retrospective population-based, cohort 
study was conducted in the Department of Dermatology 
at General Hospital in Skopje. We included all patients 
above 18 years who were admitted to the hospital with 
primary diagnosis of recurrent cellulitis of the lower legs 
between January 2016 and August 2019. All types of 
necrotizing skin and soft-tissue infections, skin infections 
in severe immunocompromised patients, post-operative 
wound infections, necrotizing fasciitis, and admissions 
where cellulitis of the lower legs was a secondary 
diagnosis have been excluded from the study.
We analyzed only the data of the hospitalized 
patients with recurrent cellulitis, defined as a second/
multiple episode of cellulitis which occurs on the same 
anatomical localization of the previous episode, at least 
1 month–1 year from the initial diagnosis. The analyzed 
data included:
Initial values of laboratory assays (leukocytes, 
granulocytes, platelets, erythrocyte sedimentation rate 
[ESR], and C-reactive protein [CRP]). Serum levels of 
glucose, transaminase, urea, creatinine, and albumin. 
The initial value of fibrinogen as an acute-phase protein 
was also recorded.
Comorbid conditions in the patients – present 
in the medical records or obtained from the interview of 
the patient (obesity – calculation of body mass index), 
diabetes mellitus (D.M), chronic kidney failure, chronic 
lung disease, hepatic cirrhosis, congestive heart failure 
and ischemic heart disease, cerebrovascular disease, 
addictions, chronic pulmonary disease, diseases of the 
thyroid gland, history of malignancy, rheumatic diseases, 
autoimmune diseases, immunosuppression, presence 
of an chronic ulcer, chronic venous insufficiency, and 
peripheral arterial occlusive disease.
Regarding statistics, Kolmogorov–Smirnov test 
was used to test the distribution of data. The categorical 
variables are represented by distribution on frequencies. 
Quantitative variables with symmetric distribution are 
shown with mean values, and the mediana was used to 
display quantitative data with asymmetric distribution. 
Student’s t-test for independent samples and Mann–
Whitney U-test were used to compare groups with 
first episode and recurrent cellulitis. The statistical 
significance was defined on level of p < 0.05.
Results
A total of 428 patients were hospitalized for 
acute cellulitis of the lower legs, but 205 of them were 
admitted for recurrent cellulitis. Table 1 displays the 
distribution of the hospitalized patient in two groups – 
patients with recurrent cellulitis – 205 patients and first 
episode cellulitis (non-recurrent cellulitis) 223 patients, 
the mean value and median of the length of stay (LOS).
Hospitalized patients with recurrent cellulitis 
had an average hospital stay of 8.81 ± 4.9 days, and 
patients without recurrence had an average LOS of 
7.71 ± 4.3 days. According to median values, half of 
patients with relapse were hospitalized for more than 
8 days and half of patients without relapse for more 
than 7 days. Statistical analysis confirmed that patients 
with recurrent cellulitis had significantly longer LOS 
than patients with first episode of cellulitis (p = 0.01) 
(Table 1).
Table 1: LOS in both recurrent and first episode cellulitis
Type of cellulitis Descriptive statistics (LOS) p-level
n Mean ± SD Min-Max Median (Q25-75)
Recurrent cellulitis 205 8.81 ± 4.9 2–30 8 (6–10) Z=2.5
Non recurrent cellulitis 223 7.71 ± 4.3 1–28 7 (5–9) p=0.01 
Mann-Whitney test, LOS: Length of stay.
Figure 1 shows a graphical representation of 
the length of stay of the two groups of respondents, 
which demonstrated statistical significance in the group 
of recurrent cellulitis.
Table 2 displays the LOS (mean values and 
median) in patients with recurrent cellulitis in correlation 
with the comorbid conditions of the patients.
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a very strong positive correlation with LOS, p < 0.001, 
p = 0.009, and p = 0.05, respectively. Hypoalbuminemia 
<34 g/L in recurrent cellulitis was also associated with 
LOS (<0.001).
Discussion
Patients with recurrent cellulitis have a longer 
LOS. Patients with recurrence had a mean LOS 8.81 ± 
4.9 days versus 7.71 ± 4.3 in the non-recurrent group, 
which was statistically significant (p = 0.01).
The LOS in recurrent cellulitis, in the study, 
was associated with certain comorbidities and 
laboratory-biochemical factors – D.M. insulin dependent 
(p < 0.001), ischemic heart disease (p = 0.006), chronic 
renal failure (p = 0.003), hepatic cirrhosis (p = 0.038), 
fever ≥38.0°C (p < 0.001), hypoalbuminemia <34 g/L 
(p < 0.001), fibrinogen value > 4 g/L (p = 0.05), elevated 
value of CRP >10 mg/L (p < 0.001), leukocytosis >109 L 
(p = 0.009), chronic ulcer (p = 0.03), and peripheral 
arterial disease (p = 0.007). Karppelin et al. in a study 
from 2010 also suggested that recurrent cellulitis has 
more difficult presentation which, in this study, was 
associated with the higher level of CRP, leukocytes, and 
granulocytes, duration of fever, and length of hospital 
stay [12]. In this study, D.M. type 2 is associated with 
prolonged hospital stay [12]. The mean LOS was 12.9 
and 9.4 days, respectively, in patients with and without 
D.M. (p = 0.064 marginally significant), indicating a 
higher hospital cost in patients with D.M. [12].
In a study by Carratala et al., hypoalbuminemia 
and renal insufficiency were identified as a risk factor for 
prolonged hospitalization in patients with cellulitis [13]. 
In this study, length of hospital stay is associated with 
following factors – age, hypoalbuminemia, and DM [13].
Infectious episodes of cellulitis are usually 
associated with significant clinical and biological signs 
of inflammation, such as fever, elevated markers of 
inflammation – serum levels of fibrinogen, and CRP, 
which were statistically analyzed and significantly 
associated in our study. Fever is not a consistent 
clinical feature and yet the absence should not preclude 
the diagnosis of cellulitis [4]. In our study, the mean 
values of the body temperature in the recurrent group 
were 37.22 ± 0.9 and 36.93 ± 0.7 in the non-recurrent 
group, respectively. The difference of slightly less than 
half a degree was statistically confirmed as significant 
(p = 0.00005). Fever often precedes any sign of skin 
inflammation and it is an important systemic feature in 
some patients [4].
We did not examine the association between 
clinical types of cellulitis with LOS, but Guberman et al., 
in a retrospective study from 1999 for bullous cellulitis 
in the lower legs, found that the median duration of 
Figure 1: Distribution of length of stay in the two groups of patients
The most significant comorbidity associated 
with increased LOS in patients with recurrent cellulitis 
is insulin-dependent D.M. (p < 0.001), with an average 
length of hospital stay – 10.05 ± 5.7. Recurrent cellulitis 
in patients with chronic kidney failure has an average 
hospital stay of 12.24 ± 5.5 which strongly correlates 
with increased LOS (p = 0.003). Positive association 
of recurrent cellulitis with increased LOS is evident 
in patients with ischemic heart disease (p = 0.006), 
peripheral artery occlusive disease (р = 0.007), hepatic 
cirrhosis (p = 0.038), and patients with chronic ulcer 
(p = 0.03).
Table 2: LOS in recurrent cellulitis and correlation with 
comorbidities
Variable n Mean ± 
SD
Min-Max p-value
Obesity (body mass index >30 kg/m2) 124 8.24 ± 4.1 2–24 NS
Insulin dependent diabetes mellitus 80 10.05 ± 5.7 2–30 <0.001
Diabetes mellitus on oral hypoglycemic agents 49 8.21 ± 3.7 2–17 NS
Chronic kidney failure 21 12.24 ± 5.5 2–24 0.003
Hepatic cirrhosis 8 10.75 ± 
4.9
3–17 0.038
History of malignancy 23 9.26 ± 5.20 2–22 NS
Autoimmune disease 21 8.95 ± 4.2 3–20 NS
Alcoholism 14 8.79 ± 2.9 5–14 NS
Iv drug addiction 1 7.0 ± 0 7 NS
Active smoking 59 9.02 ± 5.4 3–30 NS
Rheumatism 40 8.52 ± 3.8 3–21 NS
Hypothyroidism 19 8.63 ± 4.7 3–20 NS
Hyperthyroidism 3 8.0 ± 2.0 6-10 NS
Cerebro-vascular disease 25 7.8 ± 4.2 3–21 NS
Chronic pulmonary disease 20 7.95 ± 4.9 2-24 NS
Congestive heart failure 64 7.72 ± 3.9 2–22 NS
Ischemic heart disease 25 11.48 ± 6.5 4–28 0.006
Immunosuppression 30 8.7 ± 3.7 3–20 NS
Chronic ulcer 70 9.7 ± 5.5 2–30 0.03
Chronic venous insufficiency 91 7.7 ± 3.9 2–24 NS
Peripheral artery disease 93 9.6 ± 5.05 2–28 0.007
Table 3 shows the correlation between 
increased LOS in recurrent cellulitis with systemic sign 
and laboratory analyzes (markers of inflammation and 
biochemistry markers).
Table 3: LOS in recurrent cellulitis and correlation with systemic 
signs and lab analyzes
Variable n Mean ± SD Min-Max p-value
Body temperature ≥38°C 58 11.5 ± 5.7 4–30 <0.001
Albumin level <34 g/L 60 11.2 ± 6 3–30 <0.001
Fibrinogen >4 g/L 150 9.4 ± 5.1 2–30 0.05
C-reactive protein >10 mg/L 187 9.05 ± 5 2–30 <0.001
Leukocytosis>109 103 10.2 ± 5.6 2–30 0.009
Erythrocyte sedimentation rate >10 mm/h 173 8.9 ± 4.9 2–30 NS
Fever ≥38°C in patients with recurrent cellulitis 
has a very strong correlation with increased LOS 
(p < 0.001). These patients had an average hospital 
stay 11.5 ± 5.7. The markers of inflammation – elevated 
CRP level (>10.0 mg/L), leukocytosis (>109), and 
serum fibrinogen level >4g/L, in recurrent group had 
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hospitalization in patients with bullous cellulitis was 
significantly longer than in patients with non-bullous 
cellulitis [14].
In our study, the initial values of CRP were 
higher than the reference value in the majority of patients 
in both groups, but significantly more frequently in 
patients with recurrent cellulitis – 83.4% versus 69.05% 
(p = 0.000096). Patients with recurrent cellulitis had 
higher values of CRP from patients without recurrence 
(p = 0.000009). The mean and median values of this 
inflammatory parameter were 60.9 ± 62.1 and 33.6 in the 
recurrent group and 42.03 ± 50.8 and 20.85 in the non-
recurrent group, respectively. In the study of Chelsom 
et al., since 1994, it has been reported that CRP levels 
above > 200 mg/L is an indication for hospitalization 
and a high risk for developing necrotizing fasciitis [15].
Conclusion
The value of CRP, fever, and elevated serum 
level of fibrinogen correlates with LOS and disease 
severity. The value of CRP is a reflection of the severity of 
infection, which correlates with other studies of recurrent 
cellulitis [5], [6], [13]. In the study of Lazzarini et al., the 
mean CRP and ESR in the more severely ill group, with 
longer hospitalizations, was 100 mg/L and 70 mm/h, 
compared to 40 mg/L and 50 mm/h in the shorter 
hospitalization group [16]. In a retrospective study by 
Concheiro et al., the same association was statistically 
confirmed, namely, longer hospital stay is associated with 
mean ESR = 50 mm/h and mean CRP = 78 mg/L [17].
These results in terms of clinical and laboratory 
characteristics are consistent with a number of 
studies [5], [6], [12], [18], [19] that analyze risk factors 
for recurrent cellulitis of lower legs and indicate a high 
degree of clinical and biological inflammation.
In conclusion, the study has shown several 
risk factors that are associated with an increased LOS 
in patients with recurrent cellulitis. Hospital admission 
for recurrent cellulitis may be associated with 
considerable morbidity and mortality. This study allows 
us to determine and define high-risk patients present on 
admission, to ultimately improve patient care for better 
outcomes and decrease the number of relapses and 
hospital readmissions.
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